程序性死亡-话题@MedSci

#程序性死亡#

12篇内容 | 367人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1803329, encodeId=88e41803329a7, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=European Radiology：用于预测头颈部鳞状细胞癌程序性死亡配体1表达的放射组学特征, objectType=article, longId=733158, objectId=a796e33158c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a796e33158c0, replyNumber=0, likeNumber=48, createdTime=2022-08-23, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a796e33158c0, moduleTitle=European Radiology：用于预测头颈部鳞状细胞癌程序性死亡配体1表达的放射组学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a796e33158c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803328, encodeId=78651803328f1, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=J Gastroenterology：血清可溶性程序性死亡1(sPD-1)可预测慢性乙型肝炎的自发HBeAg 血清学清除程度, objectType=article, longId=726137, objectId=82c5e2613787, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82c5e2613787, replyNumber=0, likeNumber=41, createdTime=2023-04-03, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82c5e2613787, moduleTitle=J Gastroenterology：血清可溶性程序性死亡1(sPD-1)可预测慢性乙型肝炎的自发HBeAg 血清学清除程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82c5e2613787)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803327, encodeId=a701180332e42, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=Clinica Chimica Acta：可溶性程序性死亡配体1水平升高表明肝细胞癌患者接受经导管动脉化疗栓塞后免疫抑制和预后不良, objectType=article, longId=205304, objectId=1adf20530443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1adf20530443, replyNumber=0, likeNumber=29, createdTime=2021-03-23, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1adf20530443, moduleTitle=Clinica Chimica Acta：可溶性程序性死亡配体1水平升高表明肝细胞癌患者接受经导管动脉化疗栓塞后免疫抑制和预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1adf20530443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803326, encodeId=a6ab18033268c, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=Oncogene：p300/CBP抑制剂能够增强前列腺中程序性死亡配体1阻断治疗的效果, objectType=article, longId=191669, objectId=39d21916693a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39d21916693a, replyNumber=0, likeNumber=27, createdTime=2020-04-19, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39d21916693a, moduleTitle=Oncogene：p300/CBP抑制剂能够增强前列腺中程序性死亡配体1阻断治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39d21916693a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803325, encodeId=f706180332549, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=ARCH PATHOL LAB MED：使用程序性死亡配体-1 (PD-L1)染色可从良性间皮反应中分离肉瘤样恶性间皮瘤？, objectType=article, longId=187731, objectId=179b18e7319d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=179b18e7319d, replyNumber=0, likeNumber=33, createdTime=2020-07-29, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=179b18e7319d, moduleTitle=ARCH PATHOL LAB MED：使用程序性死亡配体-1 (PD-L1)染色可从良性间皮反应中分离肉瘤样恶性间皮瘤？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=179b18e7319d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803324, encodeId=fce618033242d, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=ARCH PATHOL LAB MED：免疫组化程序性死亡配体-1诊断试验的分析验证和临床应用, objectType=article, longId=167515, objectId=d40116e5156e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d40116e5156e, replyNumber=0, likeNumber=36, createdTime=2019-10-07, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d40116e5156e, moduleTitle=ARCH PATHOL LAB MED：免疫组化程序性死亡配体-1诊断试验的分析验证和临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d40116e5156e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803323, encodeId=5f0f180332320, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=ARCH PATHOL LAB MED：肿瘤浸润淋巴细胞程序性死亡受体-1的表达与非小细胞肺癌程序性死亡配体-1的表达的相关性, objectType=article, longId=153598, objectId=de43153598a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de43153598a5, replyNumber=0, likeNumber=36, createdTime=2019-01-08, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de43153598a5, moduleTitle=ARCH PATHOL LAB MED：肿瘤浸润淋巴细胞程序性死亡受体-1的表达与非小细胞肺癌程序性死亡配体-1的表达的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de43153598a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803322, encodeId=c40c1803322e8, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=J Rheumatol：皮肌炎患者中可溶性程序性死亡配体1水平升高与恶性肿瘤相关, objectType=article, longId=129494, objectId=6b8012949417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b8012949417, replyNumber=0, likeNumber=46, createdTime=2018-06-27, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b8012949417, moduleTitle=J Rheumatol：皮肌炎患者中可溶性程序性死亡配体1水平升高与恶性肿瘤相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b8012949417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803321, encodeId=ef0718033213d, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=Brit J Cancer：EB病毒相关胃癌患者程序性死亡受体表达亚型与预后, objectType=article, longId=118980, objectId=0f3811898072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f3811898072, replyNumber=0, likeNumber=38, createdTime=2018-02-05, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f3811898072, moduleTitle=Brit J Cancer：EB病毒相关胃癌患者程序性死亡受体表达亚型与预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f3811898072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803320, encodeId=cf061803320af, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=J CLIN ONCOL: Pembrolizumab治疗晚期程序性死亡因子配体 1-阳性的子宫内膜癌的安全及抗肿瘤活性（KEYNOTE-028）, objectType=article, longId=102865, objectId=a98d102865b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a98d102865b0, replyNumber=0, likeNumber=34, createdTime=2017-09-28, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a98d102865b0, moduleTitle=J CLIN ONCOL: Pembrolizumab治疗晚期程序性死亡因子配体 1-阳性的子宫内膜癌的安全及抗肿瘤活性（KEYNOTE-028）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a98d102865b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803319, encodeId=a04e1803319a5, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=J Immunol：CD38单抗Daratumumab能够引发FcR介导的细胞程序性死亡, objectType=article, longId=71459, objectId=a558e14596b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a558e14596b, replyNumber=0, likeNumber=37, createdTime=2017-02-15, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a558e14596b, moduleTitle=J Immunol：CD38单抗Daratumumab能够引发FcR介导的细胞程序性死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a558e14596b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803318, encodeId=bc891803318d7, content=<a href='/topic/show?id=9a70e52596e' target=_blank style='color:#2F92EE;'>#程序性死亡#</a>, objectTitle=J Clin Invest：发现淋巴瘤细胞逃避程序性死亡新途径, objectType=article, longId=12011, objectId=24971201108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24971201108, replyNumber=0, likeNumber=37, createdTime=2013-03-09, rootId=0, userName=12498761m56暂无昵称, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24971201108, moduleTitle=J Clin Invest：发现淋巴瘤细胞逃避程序性死亡新途径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24971201108)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

程序性死亡

2020-05-29

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

European Radiology：用于预测头颈部鳞状细胞癌程序性死亡配体1表达的放射组学特征

2022-08-23

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

J Gastroenterology：血清可溶性程序性死亡1(sPD-1)可预测慢性乙型肝炎的自发HBeAg 血清学清除程度

2023-04-03

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

Clinica Chimica Acta：可溶性程序性死亡配体1水平升高表明肝细胞癌患者接受经导管动脉化疗栓塞后免疫抑制和预后不良

2021-03-23

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

Oncogene：p300/CBP抑制剂能够增强前列腺中程序性死亡配体1阻断治疗的效果

2020-04-19

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

ARCH PATHOL LAB MED：使用程序性死亡配体-1 (PD-L1)染色可从良性间皮反应中分离肉瘤样恶性间皮瘤？

2020-07-29

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

ARCH PATHOL LAB MED：免疫组化程序性死亡配体-1诊断试验的分析验证和临床应用

2019-10-07

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

ARCH PATHOL LAB MED：肿瘤浸润淋巴细胞程序性死亡受体-1的表达与非小细胞肺癌程序性死亡配体-1的表达的相关性

2019-01-08

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

J Rheumatol：皮肌炎患者中可溶性程序性死亡配体1水平升高与恶性肿瘤相关

2018-06-27

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

Brit J Cancer：EB病毒相关胃癌患者程序性死亡受体表达亚型与预后

2018-02-05

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

J CLIN ONCOL: Pembrolizumab治疗晚期程序性死亡因子配体 1-阳性的子宫内膜癌的安全及抗肿瘤活性（KEYNOTE-028）

2017-09-28

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

J Immunol：CD38单抗Daratumumab能够引发FcR介导的细胞程序性死亡

2017-02-15

12498761m56暂无昵称 (审核中...)

前往app查看评论内容

#程序性死亡#

J Clin Invest：发现淋巴瘤细胞逃避程序性死亡新途径

2013-03-09

科室
- - 订阅+
  - 更多科室
工具
服务